Dupuytren contracture recurrence project: reaching consensus on a definition of recurrence by N. Felici et al.
350 Konsensuspaper
Felici N et al. Dupuytren Contracture Recurrence Project… Handchir Mikrochir Plast Chir 2014; 46: 350–354
received  1.10.2014
accepted  6.10.2014
Bibliography
DOI http://dx.doi.org/
10.1055/s-0034-1394420 
Online-Publikation: 20.11.2014 
Handchir Mikrochir Plast Chir 
2014; 46: 350–354 
© Georg Thieme Verlag KG 
Stuttgart · New York 
ISSN 0722-1819
Correspondence
Ignazio Marcoccio, MD
Centro di Chirurgia della Mano 
e Microchirurgia Ortopedica 
Istituto Clinico Città di Brescia 
Via Gualla 15 
25123 Brescia 
Italy 
info@ignaziomarcoccio.it
Key words
●▶	 dupuytren
●▶	 recurrence
●▶	 finger	flexion
●▶	 contracture
Schlüsselwörter
●▶	 Morbus Dupuytren
●▶	 Rezidiv
●▶	 Fingerbeugung
●▶	 Kontraktur
Dupuytren Contracture Recurrence Project: Reaching 
Consensus on a Definition of Recurrence
Morbus Dupuytren: Internationale Konsensus Konferenz zur Definition des 
Rezidivs 
Authors N. Felici1, I. Marcoccio2, R. Giunta3, M. Haerle4, C. Leclercq5, G. Pajardi6, S. Wilbrand7, A. V. Georgescu8, G. Pess9
Abstract
▼
The aim of this study was to determine a defi-
nition of recurrence of Dupuytren disease that 
could be utilized for the comparison of the results 
independently from the treatment used. 24 hand 
surgeons from 17 countries met in an interna-
tional consensus conference. The participants 
used the Delphi method to evaluate a series of 
statements: (1) the need for defining recurrence, 
(2) the concept of recurrence applied to the Tubi-
ana staging system, (3) the concept of recurrence 
applied to each single treated joint, and (4) the 
concept of recurrence applied to the finger ray. 
For each item, the possible answer was given 
on a scale of 1–5: 1 = maximum disagreement; 
2 = disagreement; 3 = agreement; 4 = strong 
agreement; 5 = absolute agreement. There was 
consensus on disagreement if 1 and 2 comprised 
at least 66 % of the recorded answers and consen-
sus on agreement if 3, 4 and 5 comprised at least 
66 % of the recorded answers. If a threshold of 
66 % was not reached, the related statement was 
considered “not defined”. A need for a definition 
of recurrence was established. The presence of 
nodules or cords without finger contracture was 
not considered an indication of recurrence. The 
Tubiana staging system was considered inappro-
priate for reporting recurrence. Recurrence was 
best determined by the measurement of a spe-
cific joint, rather than a total ray. Time 0 occurred 
between 6 weeks and 3 months. Recurrence was 
defined as a PED of more than 20 ° for at least 
one of treated joint, in the presence of a palpable 
cord, compared to the result obtained at time 0. 
This study determined the need for a standard 
definition of recurrence and reached consensus 
on that definition, which we should become the 
standard for the reporting of recurrence. If uti-
lized in subsequent publications, this will allow 
surgeons to compare different techniques and 
make is easier to help patients make an informed 
choice.
Zusammenfassung
▼
Ziel der Konsensuskonferenz in Rom war es, eine 
Definition des Rezidivs bei Morbus Dupuytren 
festzulegen, die für einen Vergleich der Ergeb-
nisse unabhängig von der gewählten Behandlung 
einsetzbar ist. 24 Handchirurgen aus 17 Ländern 
kamen im Rahmen einer internationalen Konsen-
suskonferenz zusammen. Die Teilnehmer wende-
ten die Delphi-Methode an, um folgende Thesen zu 
bewerten: (1) die Notwendigkeit einer Definition 
des Rezidivs bei Morbus Dupuytren,  das Rezidiv 
soll  (2) auf die Stadieneinteilung nach Tubiana, 
(3) für jedes einzelne behandelte Gelenk, oder 
(4) auf den Fingerstrahl angewandt werden. Jede 
These konnte auf einer Skala von 1 bis 5 bewertet 
werden: 1 = stimme gar nicht zu; 2 = stimme nicht 
zu; 3 = stimme zu; 4 = stimme sehr zu; 5 = stimme 
vollständig zu. Keine Zustimmung lag vor, wenn 
mindestens 66 % der erfassten Antworten auf 
1 und 2 entfielen und Zustimmung lag vor, falls 
mindestens 66 % der erfassten Antworten auf 3, 4 
und 5 entfielen. Falls der Schwellenwert von 66 % 
nicht erreicht wurde, wurde die jeweilige Aussage 
als „nicht definiert“ betrachtet.
Die Notwendigkeit einer Definition des Rezi-
divs bei Morbus Dupuytren wurde mit dieser 
Methode festgestellt. Das Vorliegen von Knoten 
oder Sehnen ohne Kontraktur der Finger wurde 
nicht als Anzeichen eines Rezidivs gewertet. Die 
Stadieneinteilung nach Tubiana stellte sich als 
ungeeignet zur Beschreibung eines Rezidivs her-
aus. Ein Rezidiv bei Morbus Dupuytren ist besser 
durch die Messung eines spezifischen Gelenks 
als durch eine Messung der Beugekontraktur des 
gesamten Fingerstrahls bestimmt.
Der Ausgangspunkt Null wurde definiert als Zei-
traum zwischen 6 Wochen und 3 Monaten nach 
der primären Behandlung. Ein Rezidiv wird dann 
definiert als eine passive Beugekontraktur von 
mehr als 20 ° für jedes behandelte Gelenk bei 
Vorliegen eines tastbaren Stranges, verglichen 
mit dem Ergebnis zum Zeitpunkt Null.
Affiliations Affiliation	addresses	are	listed	at	the	end	of	the	article
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Introduction
▼
Dupuytren disease (DD) is a well-known, slowly progressive 
fibroproliferative disorder that affects the hand. The very first 
medical description dates back to 1614, when Felix Plater of 
Basel reported in his Observationum the progression of ulnar fin-
ger contracture. In 1777, Henry Cline and, later in 1882, his dis-
ciple, Astley Cooper, described the role of palmar aponeurosis 
and performed a procedure similar to the modern mini-invasive 
open fasciotomy. However, it was Baron Guillaume Dupuytren, 
chief surgeon at the Hôtel-Dieu in Paris, who described the per-
manent contracture of the fingers on 5th December 1831 and 
then published his observation in 1832 in the Leçon Orales de 
Clinique Chirurgicale [1].
Despite the time elapsed, currently there is no consensus as to 
which is the gold standard for the treatment of DD, even if sur-
gery is the most common option. There are a variety of alterna-
tives for treatment, including dermofasciectomy, standard 
limited fasciectomy, segmental fasciectomy, radical fasciectomy, 
open fasciotomy, percutaneous needle fasciotomy/needle 
aponeurotomy [2–4] and the injection of collagenase Clostrid-
ium histolyticum (CCH) [5]. At the moment no outcome studies 
can absolutely sustain the superiority of one method over 
another and this is mainly due to the lack of standardization of 
the patient cohorts and the absence of a clear definition of recur-
rence [6]. The published recurrence rates are extremely variable, 
with a range from 2 to 86 % [7–9]. It seems that the selection of 
the best treatment choice largely depends on surgeon’s experi-
ence and confidence with one technique, rather than being 
based on the patient’s need, or degree and extension of the dis-
ease, or objective and scientific superiority of one technique 
over another. A clear definition of recurrence and a standard way 
to report recurrence would allow physicians to compare treat-
ments and help patients make informed decisions [10]. The 
recurrence rate thus is a key factor not only in clinical settings 
when considering treatment options, but influences economy in 
the health-care system and modifies medico-legal and insurer 
perspectives [2, 3].
In order to allow a clear comparison of the results of specific 
techniques, a clear definition of recurrence in DD is mandatory. 
A group of international hand surgeons formed a consensus con-
ference, utilizing the Delphi method, to establish that definition.
Materials and Methods
▼
The Delphi method is an iterative process to collect and distill 
the anonymous judgments of experts using a series of data col-
lection and analysis techniques interspersed with feedback. The 
Delphi method is well suited as a research instrument when 
there is incomplete knowledge about a problem or phenome-
non. The original Delphi method was developed in the 1950s by 
Norman Dalkey, of the RAND Corporation, for a US-sponsored 
military project [11]. This method is primarily based on the ano-
nymity of participants, which allows the participants to freely 
express their opinions without any social pressure to conform to 
others in the group. Decisions are evaluated on their merit, 
rather than on who has proposed the idea; on iteration, which 
allows participants to refine their views; on controlled feedback, 
informing the participants of the other participant’s perspec-
tives, which provides the opportunity to clarify or change views; 
and on statistical aggregation of group responses, which allows 
for quantitative analysis and data interpretation [12].
The Delphi method was used by the present authors to reach a 
consensus on the definition of recurrence in DD.
Based on an idea of the first author, members from the Italian 
Society for Surgery of the Hand (SICM) and the Federation of 
European Societies for Surgery of the Hand (FESSH) gathered to 
form the Scientific Committee (SC) of the Dupuytren Contracture 
Recurrence Project (DCRP). The SC developed the research state-
ments, which were divided into 4 groups: (1) the need for defin-
ing recurrence, (2) the concept of recurrence applied to the 
Tubiana staging system, (3) the concept of recurrence applied to 
each single treated joint, and (4) the concept of recurrence 
applied to the finger ray. For each item, the possible answer was 
given on a scale of 1 – 5: 1 = maximum disagreement; 2 = disagree-
ment; 3 = agreement; 4 = strong agreement; 5 = absolute agree-
ment. There was consensus on disagreement if 1 and 2 comprised 
at least 66 % of the recorded answers and consensus on agreement 
if 3, 4 and 5 comprised at least 66 % of the recorded answers. If a 
threshold of 66 % was not reached, the related statement was con-
sidered “not solved” in terms of consensus ( ●▶ Table 1).
The SC selected members from the SICM, FESSH and IFSSH based 
on their clinical experience, reputation and prior publications 
on the recurrence of DD. 62 surgeons were identified and took 
part to the DCRP. Round 1 of the Delphi method was an on-line 
questionnaire and was completed by 44 of them from 17 differ-
ent countries. The consensus conference was held in Rome on 
April 22, 2013, to discuss the results of the Delphi questionnaire 
and reach an ultimate and shared definition of DD recurrence. 
All the participants of the on-line survey were invited to Rome, 
24 hand surgeons accepted the invitation to participate. 3 addi-
tional rounds of the Delphi method were necessary to reach the 
consensus on the definition of recurrence ( ●▶ Table 2).
Results
▼
The first group of statements was the need for defining recur-
rence. The group confirmed the need to find a clear and detailed 
definition of recurrence in DD that could be applied for any 
length of follow-up.
The second group of statements was the concept of recurrence 
applied to the Tubiana staging system (Tss). The Tss utilizes an 
algebraic sum of the degree of contracture of all the treated joints 
of a specific finger ray. It was not considered to be an accurate tool 
for assessing recurrence. There was also consensus that the pres-
ence of a new hand nodule could not be considered a recurrence.
Die Konferenz zeigte die Notwendigkeit einer Definition des 
Rezidivs bei Morbus Dupuytren und führte zu einem Konsens 
in Bezug auf diese Definition. Bei Verwendung in nachfolgenden 
Publikationen wird sie es ermöglichen, verschiedene Techniken 
zu vergleichen und die Patienten beim Treffen einer informier-
ten Entscheidung zu unterstützen.
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present post-treatment (6 weeks–3 months). Finally, a standard 
degree of recurrence was needed for reporting purposes. Through 
clear consensus, a PED of more than 20 ° for at least one of treated 
joints, in the presence of a palpable cord, compared to the result 
obtained at time 0 represented the definition of recurrence.
Discussion
▼
Dupuytren disease is a slowly progressive fibroproliferative dis-
ease of unknown origin for which there is no medical cure. The 
historical definitions of recurrence, which include those of 
Heuston “the smallest palpable nodule in an operated field” [13], 
Gordon “the disease in the same area” [14], and Tubiana “the reap-
pearance of Dupuytren’s contracture tissue in a zone previously 
operated” [15], have been followed by many new definitions [2–
4, 7–10, 16]. In the report of Kan et al. [8], only 49 % of the 113 
articles studied gave a definition of recurrence. Among those, 63 % 
The third group of statements was the concept of recurrence 
applied to each single treated joint. The group determined that 
to assess an extension deficit, the measurement of the passive 
extension deficit (PED) of each treated joint should be used.
The fourth group of statements was the concept of recurrence 
applied to the finger ray. Measuring the total passive extension 
deficit (TPED) of the entire finger ray was discussed. No consensus 
was reached at the first round of Delphi. A second round defined 
an agreement in favor of the individual PED measurement of each 
treated joint, considering each joint as a separate entity.
The definition of time 0, the time when treatment results can 
be considered stable and follow-up measurements per-
formed, was also considered. It took 3 rounds of Delphi to 
reach consensus. Time 0 was defined as the period between 6 
weeks and 3 months after treatment.
At this point, the group agreed that a definition of recurrence in 
DD was necessary. It was decided which was the best way to 
measure recurrence (individual joint PED) and when time 0 was 
Table 1 Research statements – Delphi round 1.
Statement 1. Need for defining recurrence
1.1 I	think	that	a	clear	and	agreed	definition	of	the	concept	of	recurrence	in	Dupuytren’s	disease	can	be	useful.
1.2 In	the	literature,	there	is	a	definition	of	Dupuytren’s	disease	recurrence	which	is	widely	used	by	hand	surgeons	to	compare	the	results	obtained	with	
different	treatments.
1.3 The	ideal	definition	of	Dupuytren’s	disease	recurrence	should	apply	to	the	clinical	examination	of	the	hand	regardless	of	the	treatment	used.	In	this	
way,	it	would	be	possible	to	compare	the	results	obtained	with	different	techniques	(fasciectomy,	fasciotomy,	collagenase,	etc.)	by	using	the	same	
measurement.
1.4 There	is	no	need	to	define	the	concept	of	Dupuytren’s	disease	recurrence.
1.5 The	definition	of	recurrence	should	be	independent	from	the	duration	of	follow-up:	it	should	be	possible	to	apply	it	with	the	same	efficacy	after	a	
month or after several months from treatment.
Statement 2. Concept of recurrence applied to the Tubiana staging system
2.1 The new occurrence of simple hand nodules can be considered as a recurrence.
2.2 The	occurrence	of	a	flexion	retraction	causing	an	extension	deficit	to	one	of	the	finger	rays	treated	should	be	considered	as	a	recurrence.
2.3 The	return	to	the	pre-treatment	Tubiana	stage	can	be	defined	as	a	recurrence.
2.4 An increase of 1 Tubiana grade as compared to the result obtained with the treatment can be considered as recurrence.
2.5 In	patients	with	PIPs	involvement,	recurrences	are	more	common.	This	concept	should	be	considered	when	we	try	to	find	a	definition	of	recurrence	
aimed	at	assessing	exactly	what	is	the	treatment	efficacy;	therefore,	the	increase	of	1	Tubiana	stage	as	compared	to	the	result	obtained	with	the	
treatment in patients who had grade 1 or 2 at baseline and the increase of 2 Tubiana stages in patients with stage 3 or 4 at baseline can be consid-
ered as a recurrence.
2.6 The	occurrence	of	a	flexion	retraction	on	a	finger	ray	different	from	those	treated	should	be	considered	as	a	recurrence.
2.7 The	flexion	retraction	of	the	same	finger	ray	previously	treated	should	be	considered	as	a	recurrence.
2.8 In	the	Tubiana	staging	system,	the	algebraic	sum	of	the	PED	(passive	extension	deficit)	of	the	different	treated	joint	is	used	and	therefore	it	is	not	an	
accurate tool for assessing the occurrence of a recurrence.
Statement 3. Concept of recurrence applied to each single treated joint
3.1 In	order	to	obtain	an	accurate	and	specific	measure,	it	is	useful	to	measure	the	PED	(passive	extension	deficit)	of	each	treated	joint	showing	a	flexion	
retraction	and	the	TPED	(total	passive	extension	deficit)	of	each	finger	ray	before	and	immediately	after	the	treatment.
3.2 When	the	flexion	retraction	affects	the	same	joint	as	previously	treated,	it	can	be	defined	as	a	recurrence.
3.3 When	the	retraction	takes	the	single	treated	joint	back	to	the	same	pre-treatment	extension	deficit,	it	can	be	defined	as	a	recurrence.
3.4 A	recurrence	should	involve	any	PED	(passive	extension	deficit)	increase	of	one	of	the	treated	joint.
3.5 The	occurrence	of	an	extension	deficit	of		>	15	°	for	an	MP	as	compared	to	the	extension	obtained	with	the	treatment	and	the	occurrence	of	an	
extension	deficit	of		>	20	°	for	a	PIP	as	compared	to	the	extension	obtained	with	the	treatment	can	be	defined	as	a	recurrence.
3.6 The	increase	of		>	30	%	of	the	delta	between	pre-op	PED	(passive	extension	deficit)	and	post-op	PED	of	each	single	treated	joint	can	be	defined	as	a	
recurrence:	if	a	treated	joint	has	a	pre-treatment	PED	of	50	°	and	it	decreases	to	0	°	after	treatment,	a	recurrence	is	defined	as	the	occurrence	of	a	
flexion	retraction	with	a	PED	of	at	least	15	°.
3.7 An	increase	of		>	30	%	of	the	delta	between	pre-op	PED	(passive	extension	deficit)	and	post-op	PED	for	MPs	and		>	50	%	for	PIPs	can	be	considered	as	
a recurrence.
Statement 4. Concept of recurrence applied to the finger rays
4.1 The	concept	of	recurrence	should	be	applied	to	the	single	finger	ray	and	not	to	each	single	treated	joint.
4.2 A	recurrence	should	involve	an	increase	of		>	30	%	of	the	delta	between	pre-op	TPED	(total	passive	extension	deficit)	and	post-op	TPED	of	each	finger	
ray	treated:	if	the	TPED	of	a	finger	is	100	°	before	treatment	and	is	decreased	to	0	°	after	treatment,	a	recurrence	is	defined	as	the	occurrence	of	a	
flexion	retraction	with	a	TPED		>	30	°.
4.3 A	recurrence	should	involve	an	increase	of		>	90	%	of	the	delta	between	pre-op	TPED	(total	passive	extension	deficit)	and	post-op	TPED	of	each	finger	
ray	treated:	if	the	pre-treatment	TPED	of	a	finger	is	100	°	and	is	reduced	to	0	°	after	treatment,	a	recurrence	is	defined	as	the	occurrence	of	a	new	
flexion	retraction	with	a	TPED		>	90	°.
4.4 A	recurrence	should	involve	any	increase	of	the	delta	between	pre-op	TPED	(total	passive	extension	deficit)	and	post-op	TPED.
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of recurrences were based on the return of nodules or cords in the 
operated hand, 27 % were based on the return of contraction with 
an angular threshold that varied from 1 to 50 °, and 10 % were 
based on the patient’s self-report. He concluded that an interna-
tional consensus on the definition of recurrence is needed to 
allow the comparison of recurrence rates and thus treatments.
Werker et al. [9], in a selection of 21 reports, found that the defi-
nition of recurrence was qualitative in 95 % of the studies, includ-
ing the appearance of new Dupuytren’s tissue within the area 
cleared at operation, the reappearance of Dupuytren’s disease in 
the cleared operative field, and the appearance of new fascial 
bands in an area where fasciectomy had been previously per-
formed. That study indicated the importance of a quantitative 
definition of recurrence, as the possibility of comparing the 
long-term efficacy of different treatments for Dupuytren’s con-
tracture is dependent upon such a definition. To predict the 
chance of recurrence, Rombouts et al. [16] proposed a histologi-
cal staging of DD into 3 types: proliferative, fibrocellular and 
fibrous. Statistical analysis indicated a significant relationship 
between histological classification and the recurrence rate, 
which was higher in the proliferative type and lower in the 
fibrous type. An agreement on the definition of recurrence 
would allow the differentiation of true recurrence from exten-
sion of the disease [16].
The first group of statements reached consensus on the need to 
define recurrence. The significance of the presence of a new 
nodule in the operated field was discussed. The occurrence of a 
simple nodule can only be considered as an indication of recur-
rence when radical surgery is performed (fasciectomy). It is not 
an indication of recurrence after fasciotomy, needle aponeurot-
omy or CCH injection. When evaluating those treatments, the 
definition of recurrence based on the return of contracture meas-
ured in angular degrees is more appropriate. Since the aim of this 
study was to find a definition of recurrence that could be applied 
following any treatment procedure available, the presence of 
nodules or cords without finger contracture cannot be consid-
ered as an indication of recurrence. Excluding any qualitative 
methods or an anatomic description to define recurrence, only 
quantitative and functional measurements remain available.
The Tss is a measurement of the whole digital ray. The mathe-
matical sum of the degrees of contracture of the metacarpal-
phalangeal (MP) joint, proximal interphalangeal (PIP) joint and 
distal interphalangeal (DIP) joint of the affected finger ray are 
classified into 4 stages of increasing severity: 0–45 °, 45–90 °, 
90–135 ° and  > 135 °. In Tss, each stage is separated from the 
other by 45 °, which represents a wide spectrum. Another prob-
lem arises when the post-operative evaluation is made, since it 
is impossible to extract from the Tubiana stage the exact degree 
of involvement of a single affected joint. Comparison of the long-
term efficacy of different treatments for DD is only possible if a 
quantitative definition of results referring to an individual 
treated joint was applied to the measurement of outcomes dur-
ing the follow-up period. As a result of the Delphi questionnaire, 
the Tss was considered an inappropriate tool to assess recur-
rence in DD and goniometric measurement of the single treated 
joint expressed as angular degrees of PED was preferred.
When measurements of recurrence are made in terms of PED, 
the keystone parameter is the threshold angular degree over 
which recurrence is defined. In fact, the 45 ° range of each stage 
in the Tss and the 1–50 ° range in threshold variability illustrated 
Table 2 Research statements – Delphi rounds 2 and 3.
Delphi round 2
Statement 2. Concept of recurrence applied to the Tubiana staging system
2.1 The new occurrence of simple hand nodules can be considered as a recurrence.
2.2 In	patients	with	PIPs	involvement,	recurrences	are	more	common.	This	concept	should	be	considered	when	we	try	to	find	a	definition	of	
recurrence	aimed	at	assessing	exactly	what	is	the	treatment	efficacy;	therefore,	the	increase	of	1	Tubiana	stage	as	compared	to	the	result	
obtained with the treatment in patients who had grade 1 or 2 at baseline and the increase of 2 Tubiana stages in patients with stage 3 or 4 at 
baseline can be considered as a recurrence.
Statement 4. Concept of recurrence applied to the finger rays
4.1 The	concept	of	recurrence	should	be	applied	to	the	single	finger	ray	and	not	to	each	single	treated	joint.
4.2 A	recurrence	should	involve	an	increase	of		>	30	%	of	the	delta	between	pre-op	TPED	(total	passive	extension	deficit)	and	post-op	TPED	of	
each	finger	ray	treated:	if	the	TPED	of	a	finger	is	100	°	before	treatment	and	is	decreased	to	0	°	after	treatment,	a	recurrence	is	defined	as	the	
occurrence	of	a	flexion	retraction	with	a	TPED	>	30	°.
4.3 A	recurrence	should	involve	an	increase	of		>	90	%	of	the	delta	between	pre-op	TPED	(total	passive	extension	deficit)	and	post-op	TPED	of	
each	finger	ray	treated:	if	the	pretreatment	TPED	of	a	finger	is	100	°	and	is	reduced	to	0	°	after	treatment,	a	recurrence	is	defined	as	the	oc-
currence	of	a	new	flexion	retraction	with	a	TPED	>	90	°.
4.4 A	recurrence	should	involve	any	increase	of	the	delta	between	pre-op	TPED	(total	passive	extension	deficit)	and	post-op	TPED.
Statement 5. How to evaluate recurrence
5.1 In order to assess the occurrence of a recurrence a functional evaluation should be preferred to a histopathological study.
5.2 The	occurrence	of	a	finger	contracture	is	an	expression	of	a	recurrence	only	in	the	presence	of	a	palpable	cord.
5.3 Time 0: the point where treatment results can be considered stable.
– 1 pre-operative
– 2 6 weeks post-operative
– 3 3 months post-operative
– 4 6 months post-operative
5.4 The degree of contracture of each single treated joint considered as recurrence at Time 0:
– 1 any
–	2	20	°
–	3	30	°
– 4 Other
Delphi round 3
6.1 The	point	where	treatment	results	can	be	considered	stable	is	defined	as	TIME	0	and	it	is	between	6	weeks	and	3	months.
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in other reports are able to alter the recurrence rate up to 20 % 
[8]. In the current literature, the choice of angular threshold is 
variable, even though it represents the critical parameter. The 
minimum angular threshold should not be less than 5–10 °, 
which represents the measurement error of a goniometer [17]. 
In our study, we analyzed different angular degree thresholds for 
each single treated joint (any; 20 °; 30 ° and others), and consen-
sus was reached defining recurrence at greater than 20 °.
To make comparisons of results homogeneous, it is important to 
determine the time after treatment when measurements should 
begin. This is the point where treatment results can be consid-
ered stable. After 3 rounds of the Delphi method, participants in 
the consensus conference reached a consensus on the definition 
of time 0, which was set as the period between 6 weeks and 3 
months after treatment.
The development of new methods for the treatment of DD has 
broadened the options for hand surgeons. Unfortunately, there 
are no clear guidelines that allow the results of these treatments 
to be compared. There is also no method available to determine 
which of the different treatments should be utilized, according 
to the degree and stage of the disease. In the present study, the 
authors have tried to develop a standard definition of recurrence 
that could be utilized in future papers and presentations. This 
will help surgeons compare different techniques and be able to 
help patients make an informed choice. With this study the 
authors aimed to find a definition that can be applied to all the 
currently available methods of treatment, both surgical and 
non-surgical.
The definition that emerged from the consensus conference 
does not take into consideration patients’ perspective and the 
definition has not been tested on a patient cohort. Moreover, in 
the Rome conference (Delphi rounds 2 and 3) 24 surgeons par-
ticipated in respect of the 44 in round 1. These elements can be 
considered as limitations of this report.
The reduced number of participants in the Rome conference in 
the authors’ opinion did not jeopardize the result as 75 % of 
statements were solved in terms of consensus during the first 
Delphi round. In order to respect the Delphi procedures during 
the live conference the voting system was anonymous and elec-
tronically managed.
The authors are firmly convinced that the definition of recur-
rence in DD must be independent from the procedure adopted 
to treat the disease that is the reason why in the present study 
we chose not to apply the definition of recurrence on a patient 
series, leaving this chance to future reports.
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